Cargando…

Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter

BACKGROUND: Long-term gene silencing throughout cell division is generally achieved by DNA methylation and other epigenetic processes. Aberrant DNA methylation is now widely recognized to be associated with cancer and other human diseases. Here we addressed the contribution of the multifunctional nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dávalos-Salas, Mercedes, Furlan-Magaril, Mayra, González-Buendía, Edgar, Valdes-Quezada, Christian, Ayala-Ortega, Erandi, Recillas-Targa, Félix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145615/
https://www.ncbi.nlm.nih.gov/pubmed/21663659
http://dx.doi.org/10.1186/1471-2407-11-232
_version_ 1782209107456950272
author Dávalos-Salas, Mercedes
Furlan-Magaril, Mayra
González-Buendía, Edgar
Valdes-Quezada, Christian
Ayala-Ortega, Erandi
Recillas-Targa, Félix
author_facet Dávalos-Salas, Mercedes
Furlan-Magaril, Mayra
González-Buendía, Edgar
Valdes-Quezada, Christian
Ayala-Ortega, Erandi
Recillas-Targa, Félix
author_sort Dávalos-Salas, Mercedes
collection PubMed
description BACKGROUND: Long-term gene silencing throughout cell division is generally achieved by DNA methylation and other epigenetic processes. Aberrant DNA methylation is now widely recognized to be associated with cancer and other human diseases. Here we addressed the contribution of the multifunctional nuclear factor CTCF to the epigenetic regulation of the human retinoblastoma (Rb) gene promoter in different tumoral cell lines. METHODS: To assess the DNA methylation status of the Rb promoter, genomic DNA from stably transfected human erythroleukemic K562 cells expressing a GFP reporter transgene was transformed with sodium bisulfite, and then PCR-amplified with modified primers and sequenced. Single- and multi-copy integrants with the CTCF binding site mutated were isolated and characterized by Southern blotting. Silenced transgenes were reactivated using 5-aza-2'-deoxycytidine and Trichostatin-A, and their expression was monitored by fluorescent cytometry. Rb gene expression and protein abundance were assessed by RT-PCR and Western blotting in three different glioma cell lines, and DNA methylation of the promoter region was determined by sodium bisulfite sequencing, together with CTCF dissociation and methyl-CpG-binding protein incorporation by chromatin immunoprecipitation assays. RESULTS: We found that the inability of CTCF to bind to the Rb promoter causes a dramatic loss of gene expression and a progressive gain of DNA methylation. CONCLUSIONS: This study indicates that CTCF plays an important role in maintaining the Rb promoter in an optimal chromatin configuration. The absence of CTCF induces a rapid epigenetic silencing through a progressive gain of DNA methylation. Consequently, CTCF can now be seen as one of the epigenetic components that allows the proper configuration of tumor suppressor gene promoters. Its aberrant dissociation can then predispose key genes in cancer cells to acquire DNA methylation and epigenetic silencing.
format Online
Article
Text
id pubmed-3145615
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31456152011-07-29 Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter Dávalos-Salas, Mercedes Furlan-Magaril, Mayra González-Buendía, Edgar Valdes-Quezada, Christian Ayala-Ortega, Erandi Recillas-Targa, Félix BMC Cancer Research Article BACKGROUND: Long-term gene silencing throughout cell division is generally achieved by DNA methylation and other epigenetic processes. Aberrant DNA methylation is now widely recognized to be associated with cancer and other human diseases. Here we addressed the contribution of the multifunctional nuclear factor CTCF to the epigenetic regulation of the human retinoblastoma (Rb) gene promoter in different tumoral cell lines. METHODS: To assess the DNA methylation status of the Rb promoter, genomic DNA from stably transfected human erythroleukemic K562 cells expressing a GFP reporter transgene was transformed with sodium bisulfite, and then PCR-amplified with modified primers and sequenced. Single- and multi-copy integrants with the CTCF binding site mutated were isolated and characterized by Southern blotting. Silenced transgenes were reactivated using 5-aza-2'-deoxycytidine and Trichostatin-A, and their expression was monitored by fluorescent cytometry. Rb gene expression and protein abundance were assessed by RT-PCR and Western blotting in three different glioma cell lines, and DNA methylation of the promoter region was determined by sodium bisulfite sequencing, together with CTCF dissociation and methyl-CpG-binding protein incorporation by chromatin immunoprecipitation assays. RESULTS: We found that the inability of CTCF to bind to the Rb promoter causes a dramatic loss of gene expression and a progressive gain of DNA methylation. CONCLUSIONS: This study indicates that CTCF plays an important role in maintaining the Rb promoter in an optimal chromatin configuration. The absence of CTCF induces a rapid epigenetic silencing through a progressive gain of DNA methylation. Consequently, CTCF can now be seen as one of the epigenetic components that allows the proper configuration of tumor suppressor gene promoters. Its aberrant dissociation can then predispose key genes in cancer cells to acquire DNA methylation and epigenetic silencing. BioMed Central 2011-06-10 /pmc/articles/PMC3145615/ /pubmed/21663659 http://dx.doi.org/10.1186/1471-2407-11-232 Text en Copyright ©2011 Dávalos-Salas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dávalos-Salas, Mercedes
Furlan-Magaril, Mayra
González-Buendía, Edgar
Valdes-Quezada, Christian
Ayala-Ortega, Erandi
Recillas-Targa, Félix
Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
title Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
title_full Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
title_fullStr Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
title_full_unstemmed Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
title_short Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter
title_sort gain of dna methylation is enhanced in the absence of ctcf at the human retinoblastoma gene promoter
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145615/
https://www.ncbi.nlm.nih.gov/pubmed/21663659
http://dx.doi.org/10.1186/1471-2407-11-232
work_keys_str_mv AT davalossalasmercedes gainofdnamethylationisenhancedintheabsenceofctcfatthehumanretinoblastomagenepromoter
AT furlanmagarilmayra gainofdnamethylationisenhancedintheabsenceofctcfatthehumanretinoblastomagenepromoter
AT gonzalezbuendiaedgar gainofdnamethylationisenhancedintheabsenceofctcfatthehumanretinoblastomagenepromoter
AT valdesquezadachristian gainofdnamethylationisenhancedintheabsenceofctcfatthehumanretinoblastomagenepromoter
AT ayalaortegaerandi gainofdnamethylationisenhancedintheabsenceofctcfatthehumanretinoblastomagenepromoter
AT recillastargafelix gainofdnamethylationisenhancedintheabsenceofctcfatthehumanretinoblastomagenepromoter